Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical subgroupL04AC
- Chemical substanceL04AC21Bimekizumab
Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 4 medicines
Netherlands
CBG-MEB · 4 medicines



